J. Lambea

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.6K citations · Full text

Medicine, Pathology, Head And Neck Cancer +5

Assessment of the Evolution of Cancer Treatment Therapies

Manuel Arruebo, Nuria Vilaboa, Berta Sáez et al. · Cancers · 2011 · 886 citations · Full text

Nanoparticles, Cancer Therapy, Engineering +19

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

Simon Stacey, Andrei Manolescu, Patrick Sulem et al. · Nature Genetics · 2008 · 463 citations

Chromosome 5P12, Breast Oncology, Confer Susceptibility +9

SEOM clinical guidelines for the treatment of head and neck cancer (2020)

L. Iglesias, J. Lambea, Javier Martínez‐Trufero et al. · Clinical & Translational Oncology · 2021 · 98 citations · Full text

Dendritic cell uptake of iron‐based magnetic nanoparticles

Gerardo F. Goya, Iván Marcos-Campos, Rodrigo Fernández‐Pacheco et al. · Cell Biology International · 2008 · 50 citations